Covered recipient · General Payments record
TEDMUND G PO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$498.57
- Reported across 27 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $254.01 | 13 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $79.51 | 5 |
| Amgen Inc. | $43.85 | 2 |
| Lilly USA, LLC | $33.59 | 1 |
| Abbott Laboratories | $24.21 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $23.92 | 1 |
| Gilead Sciences, Inc. | $17.64 | 1 |
| SHIELD THERAPEUTICS INC | $17.10 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.21 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240994867 | CMS |
| Amgen Inc. | $25.78 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228320367 | CMS |
| Amgen Inc. | $18.07 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228320365 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $23.92 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225709904 | CMS |
| Gilead Sciences, Inc. | $17.64 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234552259 | CMS |
| Lilly USA, LLC | $33.59 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186922474 | CMS |
| Novo Nordisk Inc | $14.70 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188171019 | CMS |
| Novo Nordisk Inc | $16.42 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188811474 | CMS |
| Novo Nordisk Inc | $17.06 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188633224 | CMS |
| Novo Nordisk Inc | $14.60 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188239686 | CMS |
| Novo Nordisk Inc | $16.73 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188193204 | CMS |
| SHIELD THERAPEUTICS INC | $17.10 | 07/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249618521 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.19 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250178402 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.